Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for www.fda.gov

FDA Guidance on Promotional Labeling for Biosimilar Products

The FDA has issued new guidance addressing promotional labeling and advertising considerations for prescription reference products, biosimilar products, and interchangeable biosimilar products. The guidance aims to ensure promotional communications are accurate, truthful, and non-misleading for manufacturers and their representatives.

Priority review Guidance Pharmaceuticals
Favicon for www.fda.gov

FDA Finalizes Guidance on Drug Dispute Resolution

The FDA has finalized guidance for industry on formal dispute resolution and administrative hearings for drugs subject to final administrative orders under section 505G of the FD&C Act. This guidance provides recommendations for resolving scientific and medical disputes between the Center for Drug Evaluation and Research (CDER) and drug sponsors.

Routine Guidance Pharmaceuticals
Favicon for www.fda.gov

FDA Draft Guidance on Bayesian Methodology in Drug Trials

The FDA has issued draft guidance on the use of Bayesian methodology in clinical trials for drug and biological products. This guidance is intended for sponsors and applicants and focuses on supporting primary inference for effectiveness and safety. The agency is seeking public comments on this draft document.

Priority review Consultation Pharmaceuticals
Favicon for www.fda.gov

FDA Draft Guidance: Common Technical Document for Quality

The FDA has released draft guidance on the Common Technical Document (CTD) for the quality section of pharmaceutical registration applications. This guidance, developed under the International Council for Harmonisation (ICH), aims to harmonize the organization and presentation of quality data for human use pharmaceuticals. Comments on the draft are due by March 23, 2026.

Priority review Consultation Pharmaceuticals
Favicon for www.fda.gov

FDA Draft Guidance on Patient Preference Studies

The FDA has released draft guidance on general considerations for patient preference studies, developed under the International Council for Harmonisation (ICH). The agency is accepting public comments on this draft guidance until April 7, 2026.

Priority review Consultation Pharmaceuticals
Favicon for courts.ca.gov

Gerard v. Cuevas - Unlawful Detainer Rent Case Opinion

This document is an opinion from a California court regarding an unlawful detainer rent case, Gerard v. Cuevas. It provides a judicial interpretation of relevant housing and landlord-tenant laws.

Routine Enforcement Housing
Favicon for courts.ca.gov

Esparza v. Superior Court Case Information

This notice provides case information for Esparza v. Superior Court, identified by case number E085807. The update is from the California Courts Appellate Cases system. No specific compliance actions or deadlines are detailed.

Routine Notice Judicial Administration
Favicon for courts.ca.gov

Bartholomew v. Parking Concepts, Inc. - Civil Litigation

This document pertains to the civil case Bartholomew v. Parking Concepts, Inc., case number A171546, filed in a US court. The filing represents a new addition to the court's docket, initiating legal proceedings between the named parties.

Routine Enforcement Judicial Administration
2mo ago DOJ News
Favicon for www.justice.gov

Florida man pleads guilty to biofuel fraud conspiracy

Florida man pleads guilty to biofuel fraud conspiracy

Routine Notice
2mo ago DOJ News
Favicon for www.justice.gov

Justice Department resolves lawsuit against Pennsylvania borough zoning code

Justice Department resolves lawsuit against Pennsylvania borough zoning code

Routine Notice

Showing 28011–28020 of 28,188 changes

1 2800 2801 2802 2803 2804 2819

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.